Multiparticulate L-menthol formulations and related methods
US11207276B2 · kind B2 · utility
5Cited by
40References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2017 |
| Grant date | Dec 28, 2021 |
| Priority date | — |
| Expiry date | Aug 3, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/534
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical dosage form includes an effective amount of L-menthol for treating a gastrointestinal disorder. The L-menthol is within a plurality of particulates having a core including crystalline L-menthol dissolved in a terpene-based essential oil. A proteinaceous coating of a continuous film of proteinaceous material is over the core.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.